Chemopreventive Potential of Natural Compounds in Head and Neck Cancer

(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma

(2011) Minakshi Nihal et al.   CELL CYCLE

Lycopene in Cancer Prevention and Treatment

(2009) Soley Seren et al.   AMERICAN JOURNAL OF THERAPEUTICS

Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor

(2009) A Z Dudek et al.   BRITISH JOURNAL OF CANCER

Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck

(2009) Fa-Yu Liu et al.   BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Oral Cancer Prevention Advances with a Translational Trial of Green Tea

(2009) D. M. Shin   Cancer Prevention Research

Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail

(2009) A. M. Bode et al.   Cancer Prevention Research

Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor- B

(2009) A. R. M. R. Amin et al.   Cancer Prevention Research

Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions

(2009) A. S. Tsao et al.   Cancer Prevention Research

Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate

(2009) I. A. Siddiqui et al.   CANCER RESEARCH

Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer

(2009) F. G. Pernas et al.   CLINICAL CANCER RESEARCH

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications

(2009) G. Bar-Sela et al.   CURRENT MEDICINAL CHEMISTRY

The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol

(2009) K. Teskač et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Perspectives for Cancer Prevention With Natural Compounds

(2009) A.R.M. Ruhul Amin et al.   JOURNAL OF CLINICAL ONCOLOGY

Luteolin Induces Apoptosis in Oral Squamous Cancer Cells

(2009) S.-F. Yang et al.   JOURNAL OF DENTAL RESEARCH

Polyphenols, oral health and disease: A review

(2009) Stefano Petti et al.   JOURNAL OF DENTISTRY

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

(2009) Ezra EW Cohen et al.   LANCET ONCOLOGY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

(2009) Q. Zhou et al.   MOLECULAR CANCER THERAPEUTICS

Molecular therapy in head and neck oncology

(2009) Jacques Bernier et al.   Nature Reviews Clinical Oncology

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells

(2009) Q Sun et al.   ONCOGENE

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma

(2009) Ajay Matta et al.   Head and Neck Optical Diagnostics Society

Vegetables and Fruits in Relation to Cancer Risk: Evidence from the Greek EPIC Cohort Study

(2008) V. Benetou et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Multitargeted therapy of cancer by ellagitannins

(2008) David Heber   CANCER LETTERS

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions

(2008) V. A. Papadimitrakopoulou et al.   CLINICAL CANCER RESEARCH

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

(2008) J LOPICCOLO et al.   DRUG RESISTANCE UPDATES

Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis

(2008) Qiang Zhang et al.   FOOD AND CHEMICAL TOXICOLOGY

Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitor

(2008) Xin Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

Head and Neck Cancer Chemoprevention Gets a Shot in the Arm

(2008) Fadlo R. Khuri et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral Premalignancy

(2008) Vassiliki A. Papadimitrakopoulou et al.   JOURNAL OF CLINICAL ONCOLOGY

Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer

(2008) Johan Bussink et al.   LANCET ONCOLOGY

Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor- B and activator protein-1 related mechanisms

(2008) Z. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Multi-targeted therapy by curcumin: how spicy is it?

(2008) Ajay Goel et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Inhibition of I B Kinase-Nuclear Factor- B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin

(2008) A. L. Kasinski et al.   MOLECULAR PHARMACOLOGY

Recent Advances in Head and Neck Cancer

(2008) Robert I. Haddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise

(2007) Naghma Khan et al.   ANTIOXIDANTS & REDOX SIGNALING